Differential Effects of Dietary Components on Glucose Intolerance and Non-Alcoholic Steatohepatitis

Nutrients. 2021 Jul 23;13(8):2523. doi: 10.3390/nu13082523.

Abstract

Pharmacological treatment modalities for non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) are scarce, and discoveries are challenged by lack of predictive animal models adequately reflecting severe human disease stages and co-morbidities such as obesity and type 2 diabetes. To mimic human NAFLD/NASH etiology, many preclinical models rely on specific dietary components, though metabolism may differ considerably between species, potentially affecting outcomes and limiting comparability between studies. Consequently, understanding the physiological effects of dietary components is critical for high translational validity. This study investigated the effects of high fat, cholesterol, and carbohydrate sources on NASH development and metabolic outcomes in guinea pigs. Diet groups (n = 8/group) included: low-fat low-starch (LF-LSt), low-fat high-starch (LF-HSt), high-fat (HF) or HF with 4.2%, or 8.4% sugar water supplementation. The results showed that caloric compensation in HF animals supplied with sugar water led to reduced feed intake and a milder NASH phenotype compared to HF. The HF group displayed advanced NASH, weight gain and glucose intolerance compared to LF-LSt animals, but not LF-HSt, indicating an undesirable effect of starch in the control diet. Our findings support the HF guinea pig as a model of advanced NASH and highlights the importance in considering carbohydrate sources in preclinical studies of NAFLD.

Keywords: NASH; diet; glucose intolerance; soft drink; starch.

MeSH terms

  • Animals
  • Biomarkers / analysis
  • Biomarkers / blood
  • Body Weight
  • Cholesterol, Dietary / administration & dosage
  • Diet*
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Drinking
  • Eating
  • Energy Intake
  • Female
  • Glucose Intolerance / etiology*
  • Guinea Pigs
  • Liver / chemistry
  • Liver / pathology
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Starch / administration & dosage

Substances

  • Biomarkers
  • Cholesterol, Dietary
  • Starch